Rydex Biotechnology Fund Class Investor
Not enough financial coverage to compute a composite score for RYOIX. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.guggenheiminvestments.com/mutual-funds/fund/ryoix-biotechnology
The investment seeks to provide capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations.
- IPO
- 1998
- HQ
- Rockville, MD, US
Price Chart
Valuation
- Market Cap
- $82.99M
- Div Yield
- 11.96%
Performance & Tape
- 52W High
- $86.08
- 52W Low
- $61.11
- 50D MA
- $76.58
- 200D MA
- $76.25
- Beta
- 0.70
- Avg Volume
- 0
Get TickerSpark's AI analysis on RYOIX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RYOIX Coverage
We haven't published any research on RYOIX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RYOIX Report →